Use este identificador para citar ou linkar para este item: http://repo.saocamilo-sp.br:8080/jspui/handle/123456789/2060
Registro completo de metadados
Campo DCValorIdioma
dc.contributor.authorRiera, Rachelen_US
dc.contributor.authorBagattini, Angela Mariaen_US
dc.contributor.authorPacheco, Rafael Leiteen_US
dc.contributor.authorPachito, Daniela Viannaen_US
dc.contributor.authorRoitberg, Felipeen_US
dc.contributor.authorIlbawi, Andreen_US
dc.date.accessioned2024-09-18T18:18:22Z-
dc.date.available2024-09-18T18:18:22Z-
dc.date.issued2021-
dc.identifier.citationRiera, Rachel, et al. “Delays and disruptions in cancer health care due to COVID-19 pandemic: systematic review”. JCO Global Oncology, no 7, dezembro de 2021, p. 311–23. DOI.org (Crossref), https://doi.org/10.1200/GO.20.00639.en_US
dc.identifier.issn2687-8941-
dc.identifier.urihttp://repo.saocamilo-sp.br:8080/jspui/handle/123456789/2060-
dc.description.abstractPURPOSE :There has been noteworthy concern about the impact of COVID-19 pandemic on health services including the management of cancer. In addition to being considered at higher risk for worse outcomes from COVID-19, people with cancer may also experience disruptions or delays in health services. This systematic review aimed to identify the delays and disruptions to cancer services globally. METHODS: This is a systematic review with a comprehensive search including specific and general databases. We considered any observational longitudinal and cross-sectional study design. The selection, data extraction, and methodological assessment were performed by two independent reviewers. The methodological quality of the studies was assessed by specific tools. The delays and disruptions identified were categorized, and their frequency was presented. RESULTS: Among the 62 studies identified, none exhibited high methodological quality. The most frequent determinants for disruptions were provider- or system-related, mainly because of the reduction in service availability. The studies identified 38 different categories of delays and disruptions with impact on treatment, diagnosis, or general health service. Delays or disruptions most investigated included reduction in routine activity of cancer services and number of cancer surgeries; delay in radiotherapy; and delay, reschedule, or cancellation of outpatient visits. Interruptions and disruptions largely affected facilities (up to 77.5%), supply chain (up to 79%), and personnel availability (up to 60%). CONCLUSION : The remarkable frequency of delays and disruptions in health care mostly related to the reduction of the COVID-19 burden unintentionally posed a major risk on cancer care worldwide. Strategies can be proposed not only to mitigate the main delays and disruptions but also to standardize their measurement and reporting. As a high number of publications continuously are being published, it is critical to harmonize the upcoming reports and constantly update this review.-
dc.publisherAmerican Society of Clinical Oncologyen_US
dc.relation.ispartofJCO Global oncology, v. 7 , 2021en_US
dc.subjectAssistência integral à saúdeen_US
dc.subjectNeoplasiasen_US
dc.subjectPandemiasen_US
dc.subjectCovid-19en_US
dc.subjectRevisão sistemáticaen_US
dc.titleDelays and disruptions in cancer health care due to COVID-19 pandemic: systematic reviewen_US
dc.typeArtigo de Periódicoen_US
dc.identifier.doi10.1200/GO.20.00639-
Aparece nas coleções:Artigos de Periódicos

Arquivos associados a este item:
Não existem arquivos associados a este item.


Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.